Robert brown

Massachusetts’ health care cost containment option could affect life sciences economy

A House-Senate conference committee on Beacon Hill will soon make decisions about the health care industry in Massachusetts. While the focus of the committee’s work is cost containment, the outcome of those deliberations may have larger implications that could affect our state’s ability to compete in the international life sciences economy.

This concern comes to mind in the wake of the recent BIO Convention, which brought 15,000 biotechnology professionals from around the globe to Boston. Many visitors asked what led to the growth of the life sciences and biotechnology sector here and why so many of the leading life sciences companies decided to locate here.

Your comment is subject to the rules of our Posting Policy

This comment may appear on your public profile. Public Profile FAQ

We hope you've enjoyed your free articles.
Continue reading by subscribing to Globe.com for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com